Misconduct doctor’s ‘force made pregnant woman scream’

Dr Abdelkarim Mohamed was suspended for nine months for misconduct.

Share Button

Aberdeen sanitary product pilot to start across Scotland

The Scottish government pilot for free sanitary products for women on low incomes began in Aberdeen.

Share Button

‘Ban cartoon characters’ on unhealthy food, MPs say

Tony the Tiger and the Milky Bar Kid should no longer be used to promote items to children, MPs say.

Share Button

Ex-football stars with dementia ‘forgotten’ by authorities

A psychiatrist says he is in “no doubt there is a big problem” and more needs to be done.

Share Button

Health24.com | 5 weird things your body does

You’ve probably got out the bath after a long soak (well, not Capetonians…) and looked at your hands and feet, wondering why they look like prunes. Or wondered why, after you brushed your teeth and then drank orange juice, your mouth tastes disgusting.

Here are five weird things your body does and why.

1. Weird thing: Wrinkly fingers and toes

You’ve been soaking in the bath for some time or cooling off in the pool for hours. When you get out, your hands and feet resemble prunes.

It happens because…

Mark Changizi, an evolutionary neurobiologist at 2AI Labs in Boise, Idaho, and his colleagues, suggested in 2011 that wrinkling of wet fingers may have an evolutionary function that offered a drainage network to improve grip.

According to a recent study, published in Biology Letters, people were asked to pick up wet and dry objects (including marbles of varying sizes) with dry hands and wrinkled hands that had soaked in warm water for 30 minutes. They were able to pick up the marbles with wrinkled fingers quicker than they could with dry hands. The wrinkles, however, made no difference when it came to picking up dry objects.

“We have shown that wrinkled fingers give a better grip in wet conditions – it could be working like treads on your car tyres, which allow more of the tyre to be in contact with the road and gives you a better grip,” said Tom Smulders, an evolutionary biologist at Newcastle University, UK, and a co-author of the paper.

Smulders says it’s possible that wrinkly fingers helped our ancestors collect food from wet areas, while prune-like toes may have helped them find better footing in rainy conditions.

Although it’s clear that wrinkles offer an advantage to handling wet objects but apparently no disadvantage with dry ones, Smulders says it’s not clear why our fingers are not permanently wrinkled. But he has some suggestions, “Our initial thoughts are that this could diminish the sensitivity in our fingertips or could increase the risk of damage through catching on objects.”

Child with wrinkly hands

2. Weird thing: Orange juice tastes weird after brushing your teeth.

You’ve brushed your teeth and take a sip of orange juice. Instead of tasting delicious, fresh and sweet, it tastes so bad it makes your eyes water.

It happens because…

Scientists aren’t too sure why this happens but they do have a few theories. One has to do with sodium laureth sulphate (SLS), an ingredient in toothpaste that helps it foam and give our mouths a good clean.

The American Chemical Society explains that we have 10 000 taste buds and each one has 100 taste receptor cells. Our taste buds can taste five different taste types – sweet, sour, bitter, salty and umami.

Toothpaste has four main ingredients: water, abrasives, fluoride and detergents (that’s what creates the foam when you brush your teeth). Most toothpastes contain a detergent called sodium lauryl sulphate (SLS), which can suppress our sweetness receptors and destroy compounds called phospholipids (or bitterness inhibitors).

Your brain has a difficulty recognising that you’ve consumed something sweet. This process opens up a pathway for bitter molecules to reach sweetness receptors, which explains why drinking something like sweet orange juice soon after brushing your teeth produces a bitter and often soapy taste. 

Toothbrush and toothpaste

3. Weird thing: ‘Dead’ arm or leg

You’ve been lying on the couch watching TV with your dog curled up on your feet. You get to get something drink and fall over – your foot has gone completely numb.

It happens because…

You experience a loss of feeling in your foot due to “temporary compression of nerves”, Rebecca Traub, an assistant professor of neurology at Columbia University, told Business Insider. What happens is this: A nerve is pinched and does not communicate with the spine and brain.

Steven Vernino, a professor of neurology at the University of Texas Southwestern Medical Center and a fellow at the American Academy of Neurology, compares nerves carrying electrical signals in our body to water moving through a hosepipe.

Signals are transmitted to the brain from one part of the body; the brain recognises the signal and sends a message back. For example, when you touch a hot stove, the nerves in your hand send a signal to your brain that it’s hot; your brain interprets this as pain and makes you pull your hand away from the hot stove.

But if there is a kink in the nerve, much like water that gets stuck in a twisted hose, the signal can’t reach your brain. “One common nerve in the leg that is compressed is the fibular nerve, which travels around the side of the knee and often gets pinched when people sit with their legs crossed for a prolonged period,” said Traub.

You can rest assured, though, a dead leg is not caused by a lack of blood supply says Traub. Although it is possible to cut off the blood flow to your limb, Prof Vernino says that is rare.

man rubbing foot

4. Weird thing: A shiver down your spine

People usually say a shiver down your spine means a ghost is walking over your grave. You know the feeling; you suddenly get a shiver that involuntarily moves right down your spine and it sometimes happens when you hear a beautiful piece of music.

It happens because…

It’s normal to get goose bumps or a cold shiver down your spine when you are scared. It’s usually an indication that adrenaline is moving through your body, preparing you for fight or flight.

According to Naked Scientist, Ginny Smith, scientists aren’t entirely sure why we get shivers when we hear something beautiful. However, she says one theory exists that something unexpected can cause the same response because unexpected things can be dangerous. “So, it’s a good idea to prepare yourself in case that unexpected thing is danger. But when we know we’re not in a dangerous situation, we can actually re-interpret those bodily feelings as a kind of pleasure,” she explains.

“So, when it’s studied, these kind of tingles often come in music when there’s a sudden change in the tempo or the volume that maybe you weren’t expecting. And you get that kind of fear response but you know you shouldn’t be scared.”

Woman listening to music

5. Weird thing: Falling feeling in your sleep

You’re drifting off to sleep when your entire body jerks you awake because you feel as though you are falling or tripping.

It happens because…

This involuntary movement called a hypnagogic jerk and usually happens as you fall asleep. When you’re dreaming, your body is paralysed (which explains why you don’t move around too much) but sometimes you start to dream before your body has “switched off” completely.

Dr W Christopher Winter, Men’s Health sleep advisor and medical director of the sleep centre at Martha Jefferson Hospital in Virginia, says with hypnagogic jerks you might be acting out a dream that involves falling off a cliff, falling out of the sky or even just tripping over something.

Researchers don’t really know why you experience the feeling of falling.“It’s more likely to happen when you’re overtired, sleep-deprived or stressed,” Dr Winter says. “And your brain enters into sleep cycles more aggressively, but your body hasn’t caught up.”

woman sleeping

Do you have any weird things that happen to you that don’t make sense? Email mandy.freeman@24.com and let us know – we’ll see if we can find the answers. 

Image credit: iStock

 

NEXT ON HEALTH24X

Share Button

First 3D-printed human corneas

The first human corneas have been 3D printed by scientists at Newcastle University, UK.

It means the technique could be used in the future to ensure an unlimited supply of corneas.

As the outermost layer of the human eye, the cornea has an important role in focusing vision.

Yet there is a significant shortage of corneas available to transplant, with 10 million people worldwide requiring surgery to prevent corneal blindness as a result of diseases such as trachoma, an infectious eye disorder.

In addition, almost 5 million people suffer total blindness due to corneal scarring caused by burns, lacerations, abrasion or disease.

The proof-of-concept research, published today in Experimental Eye Research, reports how stem cells (human corneal stromal cells) from a healthy donor cornea were mixed together with alginate and collagen to create a solution that could be printed, a ‘bio-ink’.

Using a simple low-cost 3D bio-printer, the bio-ink was successfully extruded in concentric circles to form the shape of a human cornea. It took less than 10 minutes to print.

The stem cells were then shown to culture — or grow.

Che Connon, Professor of Tissue Engineering at Newcastle University, who led the work, said: “Many teams across the world have been chasing the ideal bio-ink to make this process feasible.

“Our unique gel — a combination of alginate and collagen — keeps the stem cells alive whilst producing a material which is stiff enough to hold its shape but soft enough to be squeezed out the nozzle of a 3D printer.

“This builds upon our previous work in which we kept cells alive for weeks at room temperature within a similar hydrogel. Now we have a ready to use bio-ink containing stem cells allowing users to start printing tissues without having to worry about growing the cells separately.”

The scientists, including first author and PhD student Ms Abigail Isaacson from the Institute of Genetic Medicine, Newcastle University, also demonstrated that they could build a cornea to match a patient’s unique specifications.

The dimensions of the printed tissue were originally taken from an actual cornea. By scanning a patient’s eye, they could use the data to rapidly print a cornea which matched the size and shape.

Professor Connon added: “Our 3D printed corneas will now have to undergo further testing and it will be several years before we could be in the position where we are using them for transplants.

“However, what we have shown is that it is feasible to print corneas using coordinates taken from a patient eye and that this approach has potential to combat the world-wide shortage.”

Reference:

3D Bioprinting of a Corneal Stroma Equivalent. Abigail Isaacson, Stephen Swioklo, Che J. Connon. Experimental Eye Research.

Story Source:

Materials provided by Newcastle University. Note: Content may be edited for style and length.

Share Button

New motor neurone brace makes ‘substantial difference’

One patient had “no doubt” that the Sheffield-designed collar had improved his quality of life.

Share Button

Smell receptor fuels prostate cancer progression

When scientists first described the receptors responsible for our sense of smell, they naturally assumed that these chemical sensors resided exclusively in the lining of our noses.

But then olfactory receptors started turning up in the strangest places — the lungs, liver, skin, heart, testes and intestines. Nearly a quarter of a century later, researchers are still wondering what these receptors are doing in such disparate locations.

Duke researchers have shown in new research that one olfactory receptor plays a critical role in the progression of prostate cancer. They found that activating an olfactory receptor called OR51E2 in prostate cancer cells caused the cancer to morph into the more aggressive, ‘castration-resistant’ form of the disease.

The finding suggests that taking the opposite approach — blocking the receptor with specific molecules, or perhaps even with specific scents — could provide a new way to treat prostate cancer.

“When you smell a specific odor, the molecules you inhale go into your bloodstream. So one day, we may be able to use an odorant to cure prostate cancer — though it’s not possible yet,” said Hiroaki Matsunami, Ph.D., senior author of the study and professor of molecular genetics and microbiology at Duke University School of Medicine. The research is published May 28 in Frontiers in Oncology — Genitourinary Oncology.

Olfactory receptors belong to a family of proteins called G protein-coupled receptors or GPCRs, which are the most commonly exploited drug target in modern medicine. These receptors act by a lock and key mechanism. When the right molecular “key” fits into the receptor’s “lock,” it sets off a cascade of biochemical reactions that culminate in a specific biological activity, such as the brain recognizing the scent of freshly cut grass.

Thus far, Matsunami’s lab has identified the molecular keys or “ligands” that activate more than 50 different olfactory receptors, most involved in smell and other senses.

But Tatjana Abaffy, Ph.D., a research assistant professor working with Matsunami, was interested in olfactory receptors that are present outside the nose. She found repeated mentions in the scientific literature of a receptor called OR51E2 present in such unusually high levels in prostate cancer cells that it earned the alternate moniker Prostate-Specific G Protein-Coupled Receptor (PSGR).

To find the ligands that bind OR51E2 — the first step to figuring out what role it might play in prostate cancer cells — Abaffy made a virtual model of the olfactory receptor. She then trained a computer to screen a library of 2,516 different human metabolites and pick out the ones most likely to unlock the virtual receptor. Abaffy took the top 100 most promising candidates from that virtual screen and added them to living cells to see which ones activated the receptor.

A couple dozen ligands, including a steroid called 19-hydroxyandrostenedione or 19 OH-AD, caused the cancer cells to take on the characteristics of neuroendocrine cells. Most deaths from prostate cancer are due to the progression of localized disease into metastatic, castration-resistant prostate cancer, which is characterized by an increased number of these neuroendocrine-like cells.

“The typical therapy for patients with prostate cancer involves eliminating cancer-fueling hormones like testosterone by chemical or surgical castration,” said Abaffy, who is lead author of the study. “This approach slows down the cancer, but resistance typically develops after a year or two, resulting in castration-resistant prostate cancer. We believe the olfactory receptor is involved at this stage of the disease.”

Abaffy also found that cancer cells secrete 19 OH-AD, which acts as a critical intermediate in the chemical conversion of testosterone into estrogen, essentially feeding their own progression. But when she eliminated the olfactory receptor from the cells, 19 OH-AD lost its effect, and the progression stalled.

“By identifying molecules that can activate or block this receptor, we could change the course of prostate cancer,” Matsunami said.

With that goal in mind, the researchers are currently conducting follow-up experiments with the other compounds uncovered in this study.

Share Button

Self-tuning brain implant could help treat patients with Parkinson’s disease

Deep brain stimulation has been used to treat Parkinson’s disease symptoms for 25 years, but limitations have led researchers to look for ways to improve the technique. This study describes the first fully implanted DBS system that uses feedback from the brain itself to fine-tune its signaling. The study was supported by the National Institutes of Health’s Brain Research through Advancing Innovative Technologies (BRAIN) Initiative and the National Institute of Neurological Disorders and Stroke (NINDS).

“The novel approach taken in this small-scale feasibility study may be an important first step in developing a more refined or personalized way for doctors to reduce the problems patients with Parkinson’s disease face every day,” said Nick B. Langhals, Ph.D., program director at NINDS and team lead for the BRAIN Initiative.

Deep brain stimulation is a method of managing Parkinson’s disease symptoms by surgically implanting an electrode, a thin wire, into the brain. Traditional deep brain stimulation delivers constant stimulation to a part of the brain called the basal ganglia to help treat the symptoms of Parkinson’s. However, this approach can lead to unwanted side effects, requiring reprogramming by a trained clinician. The new method described in this study is adaptive, so that the stimulation delivered is responsive in real time to signals received from the patient’s brain.

“This is the first time a fully implanted device has been used for closed-loop, adaptive deep brain stimulation in human Parkinson’s disease patients,” said Philip Starr, M.D., Ph.D., professor of neurological surgery, University of California, San Francisco, and senior author of the study, which was published in the Journal of Neural Engineering.

In a short-term feasibility trial, two patients with Parkinson’s received a fully implanted, adaptive deep brain stimulation device. The device differs from traditional ones in that it can both monitor and modulate brain activity. In this work, sensing was done from an electrode implanted over the primary motor cortex, a part of the brain critical for normal movement. Signals from this electrode are then fed into a computer program embedded in the device, which determines whether to stimulate the brain. For this study the researchers taught the program to recognize a pattern of brain activity associated with dyskinesia, or uncontrolled movements that are a side effect of deep brain stimulation in Parkinson’s disease, as a guide to tailor stimulation. Stimulation was reduced when it identified dyskinesia-related brain activity and increased when brain sensing indicated no dyskinesia to minimize deep brain stimulation-related side effects.

Results of initial, short-term studies aimed at demonstrating feasibility and effectiveness of using adaptive deep brain stimulation to overcome the impediment to movement of Parkinson’s suggested that this adaptive approach was equally effective at controlling symptoms as traditional deep brain stimulation. Doctors saw and patients noticed no differences in the improvement in movement under adaptive stimulation versus constant, open loop stimulation set manually by the researchers. Because adaptive deep brain stimulation did not continuously stimulate the brain, the system saved about 40 percent of the device’s battery energy used during traditional stimulation. The short time periods over which movement was assessed did not permit comparison of the two deep brain stimulation paradigms relative to incidence of dyskinesia, but it is hoped that the variable stimulation will also translate into a reduction in adverse effects when tested over longer time periods.

“Other adaptive deep brain stimulation designs record brain activity from an area adjacent to where the stimulation occurs, in the basal ganglia, which is susceptible to interference from stimulation current” said Dr. Starr. “Instead, our device receives feedback from the motor cortex, far from the stimulation source, providing a more reliable signal.”

Many patients with Parkinson’s disease who would benefit from deep brain stimulation are difficult to treat because too much stimulation can cause dyskinesia. Thus, finding the correct level of stimulation is like trying to hit a constantly moving target. An adaptive system like the one being tested here could offer an effective alternative and may also limit adverse effects of traditional deep brain stimulation, but considerable testing remains to be done.

“Here we have demonstrated the feasibility of adaptive deep brain stimulation,” said Dr. Starr. “We are now planning larger, longer-term trials to determine how effective this system is in managing the symptoms of patients with Parkinson’s disease.”

Share Button

Vaccine for cancer that killed Tessa Jowell ‘remarkably promising’

A treatment for the cancer that killed Tessa Jowell could help to extend lives, a trial suggests.

Share Button